Navneet Arora

Navneet Arora

Auto-generated profile, based on publicly available information

Navneet Arora

Department of Internal Medicine, PGIMER, Chandigarh, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
NANavneet Arora
Navneet Arora
LALokhesh C Anbalagan
Lokhesh C Anbalagan
APAshok Pannu
Ashok Pannu
Background: Recent advances in mosquito eradication and antimalarial treatments have reduced the malaria burden only modestly. An effective malaria vaccine remains a high priority, but its development has several challenges. Among many potential candidates, the RTS,S/AS01 vaccine (MosquirixTM) remains the leading candidate. Objective and Method: This review aims to understand the advances in the RTS,S/AS01 vaccine, and future comments regarding the vaccine’s effectiveness in malaria eradication. Literature review for the past five decades was performed searching PubMed, EMBASE Ovid, and Cochrane Library, with using the following search items: (“malaria” OR “WHO’s malaria” OR “Plasmodium falciparum” OR “RTS,S” OR “RTS,S/AS01” OR “RTS,S/AS02” OR “pre-erythrocytic malaria” OR “circumsporozoite” OR “Mosquirix”) AND (“vaccine” OR “vaccination”). Results: RTS,S/AS01, a recombinant pre-erythrocytic vaccine containing Plasmodium falciparum surface-protein (circumsporozoite) antigen, is safe, well-tolerated, and immunogenic in children. Three doses, along with a booster, have a modest efficacy of about 36% in children (age 5– 17 months) and about 26% in infants (age 6– 12 weeks) against clinical malaria during a 48-month follow-up. However, the efficacy varies among population subgroups and with the parasite strain, it reduces without a booster and offers protection for a limited duration. Because of its potential cost-effectiveness and positive public health effect, the vaccine is being investigated in a pilot program for mortality benefits and broader deployment. Conclusion: The RTS,S/AS01 vaccine prevents malaria; however, it should be considered another addition to the malaria-control program and not as an eradication tool because of its relatively low to modest efficacy.

1 November 2021 in Indian Heart Journal
Verified
Journal Article
Open access
NANavneet Arora
Navneet Arora
PPPrashant Kumar Panda
Prashant Kumar Panda
PCPruthvi Cr
Pruthvi Cr
LULipi Uppal
Lipi Uppal
ASAtul Saroch
Atul Saroch
APAshok Pannu
Ashok Pannu
Several studies have demonstrated a shift in the spectrum of infective endocarditis (IE) in the developed world. We aimed to investigate whether demographic and microbiologic characteristics of IE have changed in India. A retrospective analysis of patients with in north India between 2010 and 2020. The clinical and laboratory profiles of 199 IE admitted to an academic hospital patients who met the modified Duke criteria for definite IE were analysed. The mean age was 34 years, and 84% were males. The main predisposing conditions were injection drug use (IDU) (n = 71, 35.7%), congenital heart disease (n = 46, 21.6%), rheumatic heart disease (n = 25, 12.5%), and prosthetic device (n = 19, 9.5%). 17.1% of patients developed IE without identified predispositions. Among 64.3% culture-positive cases, the most prevalent causative pathogens were Staphylococcus aureus (46.1%), viridans streptococci (7.0%), enterococci (6.0%), coagulase-negative staphylococci (5.5%), gram negative bacilli (5.5%), polymicrobial (5.5%), and Candida (1.0%). The tricuspid (30.3%), mitral (25.6%), and aortic (21.6%) valves were the most common sites of infection, and 60.3% had large vegetations (>10 mm). Systemic embolization occurred in 55.3% of patients at presentation. Cardiac surgery was required for 13.1%. In-hospital mortality was 17.1% and was associated with prosthetic devices (p-value, 0.001), baseline leucocytosis (p-value, 0.036) or acute kidney injury (p-value, 0.001), and a microbial etiology of gram negative bacilli or enterococci (p-value, 0.005). IDU is now the most important predisposition for IE in India, and S. aureus has become the leading cause of native valve endocarditis with or without IDU.

22 November 2021 in Drug Metabolism Letters
Verified
Journal Article
Closed access
PDF file
LALokhesh C. Anbalagan
Lokhesh C. Anbalagan
NANavneet Arora
Navneet Arora
APAshok Pannu
Ashok Pannu
Due to its easy availability, rapid and severe toxicity, and no specific antidote, aluminum phosphide has emerged as a lethal toxin, commonly used for suicidal intent in agricultural communities. Despite various advances in medicine, this compound’s toxicity is poorly understood, and it still has a very high case fatality rate with no definitive treatment options available. This review aims to understand the mechanism of toxicity, clinical toxidrome of acute aluminum phosphide poisoning, and the available therapeutic options, including recent advances. A literature review was performed searching PubMed, EMBASE Ovid, and Cochrane Library, using the following search items: (“aluminum phosphide poisoning” OR “aluminum phosphide poisoning toxicity” OR “aluminum phosphide ingestion”) AND (“management” OR “therapy” OR “treatment”). Selected articles were discussed amongst all the authors to shape this review. High case fatality rate and lack of any specific antidote are persisting challenges. Therapeutic measures need to be implemented from all fronts – reducing easy access to the poison, developing less toxic alternatives for use as a pesticide, and more studies directed at developing an effective reversal agent for phosphine. The advent of promising agents like glucose-insulin-potassium infusion and lipid emulsion is a new ray of hope in the complete recovery in this fatal poisoning. The need of the hour is to find an agent that rapidly and effectively reverses aluminum phosphide's toxic effects. Large multicenter controlled trials are required to establish the role of glucose-insulin-potassium and lipid emulsion.

1 December 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
DDDeba Prasad Dhibar
Deba Prasad Dhibar
NANavneet Arora
Navneet Arora
AKArpit Kakkar
Arpit Kakkar
NSNeeraj Singla
Neeraj Singla
RMRitin Mohindra
Ritin Mohindra
BMBikash Medhi
Bikash Medhi

27 July 2021 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
NANavneet Arora
Navneet Arora
DKDevender Kumar
Devender Kumar
RKRavindran Kiran
Ravindran Kiran
APAshok Pannu
Ashok Pannu

1 July 2022 in Journal of Gastrointestinal Infections
Verified
Journal Article
Open access
PDF file
SWSarthak Wadhera
Sarthak Wadhera
NANavneet Arora
Navneet Arora
DDDeba Prasad Dhibar
Deba Prasad Dhibar
An encapsulated collection of suppurated material within the liver is termed a liver abscess, which may be caused due to bacterial, parasitic, or fungal infection. Liver abscesses can be divided into infectious, iatrogenic, and malignant. Infection spreading through the biliary tract is the most common cause now. Escherichia coli, the most common organism causing liver abscess two decades ago, is replaced by Klebsiella pneumonia, accounting for 50 to 70% of cases in the Asian subcontinent; however, liver abscesses due to Entameba histolytica are also found quiet often in day to day clinical practice. Risk factors associated with the development of liver abscess are increasing age, male sex, presence of underlying diabetes mellitus, liver cirrhosis, continuous use of proton pump inhibitors, and immunocompromised state. Fever and abdominal pain are the typical clinical symptoms of a liver abscess. Other common symptoms include nausea, vomiting, malaise, and chills. Tachycardia, right upper quadrant tenderness, and hepatomegaly are common examination findings. USG of the abdomen is performed in all suspected cases of liver abscess and has a sensitivity of 85%. Small abscesses, less than 3 to 4 cm, can be managed with antibiotics. Percutaneous drainage can be done either by single-time needle aspiration or catheter drainage.